MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Identification of atlastin genetic modifiers in a Hereditary Spastic Paraplegia model in Drosophila

    P. Olguin, N. Candia, A. Ibacache, I. Medina-Yañez, G. Olivares, M. Ramirez, F. Vega-Macaya, A. Couve, J. Sierralta (Santiago, Chile)

    Objective: To identify genetic modifiers of decreased locomotion and neuromuscular junction defects associated with atlastin knockdown in motor neurons. Background: Hereditary spastic paraplegias (HSPs) are…
  • 2023 International Congress

    Are GDNF receptors the gatekeepers of GDNF efficacy during progressive nigrostriatal neuron loss?

    M. Salvatore, E. Kasanga, Y. Han, R. Mcmanus, W. Navarrete, V. Nejtek, J. Richardson (Fort Worth, USA)

    Objective: To determine if GDNF receptor expression levels in the striatum or substantia nigra (SN) change in relation to differences in tyrosine hydroxylase (TH) and…
  • 2023 International Congress

    Corticobasal Syndrome (CBS), Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) Cohort in Central New York

    M. Iqbal, T. Chabrashvili (Syracuse, USA)

    Objective: Aims: The goal of this retrospective study was to characterize a CBS, CBD and PSP cohort and demonstrate that the Electronic Medical Record (EMR)…
  • 2023 International Congress

    Transition among HD-ISS stages as an endpoint in clinical trials for HD

    J. Mills, J. Long, J. Vaidya, S. Sathe, C. Sampaio, S. Tabrizi (Iowa City, USA)

    Objective: Investigate the time to the event of HD-ISS Stage 3 transition (functional change) as an endpoint for clinical trials in Huntington’s disease (HD) and…
  • 2023 International Congress

    Diffusion Tensor Imaging of Spinocerebellar ataxia type 12 patients in comparison of Healthy control

    AK. Srivastava, P. Pankaj, S. Kumaran, A. Garg, R. Agarwal, A. Nehra, F. Mohammad (New Delhi, India)

    Objective: To assess changes in brain tissue microstructures using diffusion tensor imaging parameters, fractional anisotropy (FA), increased radial (RD) and axial diffusivities (AD) in SCA…
  • 2023 International Congress

    Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.

    K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, F. Tanaka (Yokohama, Japan)

    Objective: To clarify the the clinical background of Parkinson's disease patients with DBS who received multiple stimulus targets. Background: Deep brain stimulation (DBS) is an…
  • 2023 International Congress

    Association between Stress and Bruxism in Egyptian University Female Students Throughout Their Final Exam Period

    MYA. Amine, U. Dakrory (Giza, Egypt)

    Objective: The Current study highlights the correlation between bruxism and stress in a group of Egyptian university students. Background: Bruxism is an involuntary contraction of…
  • 2023 International Congress

    The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson’s disease

    W. Li, R. Li, J. Lu (Beijing, China)

    Objective: To evaluate the effect of apolipoprotein E 4 (APOE 4) on striatal vesicular monoamine transporter-2 (VMAT2) density in Parkinson’s disease (PD).To evaluate the effect…
  • 2023 International Congress

    Effect of ADX-88178, a highly-selective mGlu4 PAM, on parkinsonism, dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

    I. Frouni, C. Kwan, D. Bédard, W. Kang, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To investigate the effect of the metabotropic glutamate 4 (mGlu4) positive allosteric modulator (PAM) ADX-88178 on parkinsonism, dyskinesia and psychosis-like behaviours (PLBs) in the…
  • 2023 International Congress

    Metoclopramide-induced acute dystonic reaction caused by CYP2D6 *4/*4 and CYP2D6 *10/*10 genotypes

    I. šarac, H. šarac, F. Borovečki, N. Božina, I. Ivek, L. Bagarić Krakan, Z. Krešić (Zagreb, Croatia)

    Objective: Objective is to demonstrated the role of CYP P450 2D6 polymorphisms in metoclopramide-induced acute dystonic reactions. Background: Metoclopramide can induce acute extrapyramidal reactions by…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley